(Q34408021)

English

Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Carina S D Wink

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Golo M J Meyer

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dirk K Wissenbach

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Andrea Jacobsen-Bauer

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Markus R Meyer

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hans H Maurer

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

3 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Drug Testing and Analysis

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1038-1048

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

describes a project that uses

gas chromatography-mass spectrometry

1 reference

based on heuristic

inferred from title

Opioid activity of lefetamine

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Lefetamine: new abuse of an old drug--clinical evaluation of opioid activity

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Fragmentation mechanisms of protonated benzylamines. Electrospray ionisation-tandem mass spectrometry study and ab initio molecular orbital calculations

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

To scale or not to scale: the principles of dose extrapolation

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument?

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

21 January 2018

Gas chromatographic-mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi d

1 reference

https://api.crossref.org/works/10.1002%2FDTA.1621

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DTA.1621

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34408021&oldid=1878304231"